FDA
-
-
-
-
-
-
-
Valneva Reports Full Year 2024 Results and Provides Business Updates and Outlook
-
-
-
-
-
-
-
Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine
-
-
-
-
-
-
-
Valneva Provides Clinical and Regulatory Updates for its COVID-19 Vaccine VLA2001
-
-
-
-
-
-
-
Tesla, Meta Platforms, and Valneva rise premarket
-
-
-
-
-
-
-
Valneva Provides Further Update on its COVID-19 Activities
-
-
-
-
-
-
-
Valneva Reports H1 2022 Results and Provides Corporate Updates
-
-
-
-
-
-
-
Valneva (VALN) Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001
-
322,094 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

